Pf Media

Supporting pharma, life sciences and health.
Stay up to date on #AllThingsPharma
New role? Visit @PharmaJobsUK
The premier pharmaceutical awards @Pf_Awards

[Pf Media @Pharmafield]

The Spring issue of Pf Magazine is out now, with a look at what the future holds for #pharma. Now that digital relationships have been built, how do we make them sustainable? And how do we keep them relevant? https://t.co/o4JCSs7tbi

[Pf Media @Pharmafield]

New MHRA Chief Executive Officer appointed - Pf Media https://t.co/r2adPoml86

[Pf Media @Pharmafield]

The impact of EU pharmaceutical reform - Pf Media https://t.co/Ia7EgsejSb

[Pf Media @Pharmafield]

Go-to-market innovation in 2028: Essential disruption dimensions for thriving in the new European healthcare landscape - Pf Media https://t.co/WwE17oDQCT

[Pf Media @Pharmafield]

Go-to-market innovation in 2028: Essential disruption dimensions for thriving in the new European healthcare landscape - Pf Media https://t.co/Hfxx9dd3wF

[Pf Media @Pharmafield]

Dare to be disruptive – how to model your European go to market strategy for success  - Pf Media https://t.co/ZvRPK7fV0j

[Pf Media @Pharmafield]

Novartis' leukaemia treatment to be made available on the NHS - Pf Media https://t.co/z6mqXkQpC7

[Pf Media @Pharmafield]

NICE recommends new Novartis treatment for brain tumours - Pf Media https://t.co/FHdAjF21c1

[Pf Media @Pharmafield]

Promising new treatment strategy for aggressive form of leukaemia - Pf Media https://t.co/sl5HAY1Rd9

[Pf Media @Pharmafield]

Positive trial results for PharmNovo's pain management drug - Pf Media https://t.co/UbZ3gnGgMj

[Pf Media @Pharmafield]

Research uncovers how to target dormant breast cancer cells and prevent relapse - Pf Media https://t.co/Z6rpSqv3qy

[Pf Media @Pharmafield]

HCP engagement solutions – being present isn’t enough - Pf Media https://t.co/8AFZUU9Xbm

[Pf Media @Pharmafield]

Almirall expands pipeline to rare dermatological diseases - Pf Media:
https://t.co/rGpzSswDAl

[Pf Media @Pharmafield]

SMC accepts AbbVie’s new Parkinson’s drug within NHS Scotland - Pf Media
https://t.co/8O28DE5Zrw

[Pf Media @Pharmafield]

NICE recommends Janssen’s rare disease treatment - Pf Media https://t.co/5POimbjFOp

[Pf Media @Pharmafield]

Besins Healthcare appoints new General Manager - Pf Media https://t.co/ltoXlIVnvh

[Pf Media @Pharmafield]

MHRA licenses treatment option for rare autoimmune disease - Pf Media https://t.co/DrDIKBorDV

[Pf Media @Pharmafield]

VPAG survey – have your say - Pf Media https://t.co/BsPVd7oUQL

[Pf Media @Pharmafield]

Kyowa Kirin to acquire Orchard Therapeutics   - Pf Media https://t.co/QWniSxZLBc

[Pf Media @Pharmafield]

MHRA grants marketing authorisation for LEO’s dermatitis treatment - Pf Media https://t.co/UDC9kIqZUj

[Pf Media @Pharmafield]

First treatment for acute migraine recommended by NICE - Pf Media https://t.co/bSrkJibEk3